Home / Inspections / 1232210

FDA Inspection 1232210 — Genzyme Corporation

Genzyme Corporation — FEI 1220423

The FDA completed an inspection of Genzyme Corporation on July 9, 2024 in Framingham, MA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
July 9, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Framingham, MA (United States)

Facility

Other inspections at this facility

  • 1294652 (VAI Thu Apr 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1176107 (VAI Mon Jul 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1003362 (NAI Thu Feb 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 904958 (VAI Fri Nov 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 897241 (VAI Thu Sep 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources